Search results for Glp-1 Pregnancy Safety

Neonatal and Obstetric Outcomes Following Periconceptional Exposure to Glucagon-Like Peptide-1 Receptor Agonists: A Syst...

To evaluate the association between periconceptional exposure to glucagon-like peptide-1 receptor agonists and fetal, pregnancy-related, obstetric, and delivery outcomes.

GLP-1s may not raise DKA, pancreatitis risk in type 1 diabetes

LAS VEGAS — GLP-1 receptor agonists may not raise the risk for diabetic ketoacidosis or pancreatitis among adults with type 1 diabetes, according to the findings from a single-cent...

GLP-1 use shows ‘far higher’ than expected risk for residual gastric content in endoscopy

Use of GLP-1s or glucose-dependent insulinotropic polypeptide agonists before upper endoscopy significantly increased the risk for residual gastric volume, according to data publis...

How safe are GLP-1 drugs, really?

GLP-1 medications have exploded in popularity over the past few years, and it’s easy to see why. They work. People lose significant weight, blood sugar improves, and for the first...

GLP-1 use prior to TJA yielded higher rates of malnutrition

NEW ORLEANS — Patients taking GLP-1 agonists before total joint arthroplasty experienced significantly higher rates of preoperative nutritional deficiencies, according to results p...

559 REAL WORLD GI SAFETY COMPARISON OF SEMAGLUTIDE AND TIRZEPATIDE: A PHARMACOVIGILANCE STUDY

GLP-1s reduced ED visits, infections and revisions in orthopedics

NEW ORLEANS — Results presented here showed GLP-1 receptor agonists may be associated with lower ED utilization and a reduction in surgical site infections and revisions for a rang...

GLP-1 Receptor Agonists and Upper Endoscopy – Guidance for Periprocedural Management

<![CDATA[How Many GLP-1 Users Must Seek Medical Care for Side Effects?]]>

GLP-1 Drugs May Improve Breast Cancer Outcomes

WEDNESDAY, May 13, 2026 — Popular GLP-1 medications may be linked to better long-term outcomes for some breast cancer patients. Previous research has shown breast cancer survivors...

Study finds nutritional risks in users of GLP-1 drugs

Adults with overweight or obesity taking the new generation of weight loss drugs semaglutide and tirzepatide tend to eat significantly less, leaving them vulnerable to nutritional...

GLP-1s sustain weight loss in IBD, obesity without worse symptoms

CHICAGO — Patients with obesity and inflammatory bowel disease showed improved bowel function while receiving GLP-1 receptor agonists and lifestyle counseling, in contrast to the g...

Preoperative Nutritional Resilience in the Era of GLP-1 Therapy: Implications for Body Contouring Surgery

The expanding use of GLP-1 receptor agonists in the treatment of obesity is reshaping the metabolic profile of patients presenting for surgery. Although these agents are highly eff...

Local GLP-1 user loses 105 pounds, suffers few side effects

The use of GLP-1 medications for weight loss has skyrocketed, but there are side effects.

Su1917 THE IMPACT OF GLP-1 RECEPTOR AGONISTS ON NEOPLASTIC PANCREATIC CYST BEHAVIOR

GLP-1 Receptor Agonist Weight Loss Therapy and Arthroplasty: Are Women at Greater Risk for Complications?

The GLP-1 receptor agonists have profoundly revolutionized metabolic therapy. These agents have rapidly become central to obesity management, producing substantial effects on weigh...

The effect of metformin on perinatal outcomes in pregnant women with type 2 diabetes differs by baseline insulin require...

Metformin works by increasing insulin sensitivity, which may aid in the management of insulin-treated type 2 diabetes in pregnancy. However, large trials have found that adjunctive...

GLP-1 drugs may reduce the risk of cancer progressing, study suggests

GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the American Society of Clinical Oncology’s annual me...

GLP-1 Drugs May Trigger Muscle Loss In Cirrhosis Patients: Study

GLP-1 drugs are often praised for their metabolic benefits, including improved blood sugar control and weight reduction. However, in patients with liver cirrhosis, these benefits m...

GLP-1 Users May Experience A Surprising Life-Saving Benefit That Has Nothing To Do With Weight Loss

A new study found that some cancer patients who took GLP-1 drugs saw some remission — especially if they had breast cancer.

Doctors Reveal The Most Common Side Effects Of GLP-1s — And How To Manage Them

Ozempic, Wegovy and other GLP-1 medications are popular but can cause unwanted health concerns.

GLP-1 drugs reduce risk of major adverse cardiovascular events

New research has shown that GLP‑1 weight-loss drugs deliver protection against heart attacks, strokes and premature death over a sustained period of time.

Why Patients Discontinue GLP-1 Treatments: A Look at Side Effects

Why Patients Discontinue GLP-1 Treatments: A Look at Side Effects Anonymous (not verified) Thu, 04/23/2026 - 11:13 pharmagather item url Why Patients Disco...

Pregnancy Safe For Women With Myasthenia Gravis, Study Concludes

MONDAY, May 18, 2026 — Women suffering from the muscle weakness disease myasthenia gravis can become pregnant without any ill effects, a new study says. Pregnancy is not linked wit...